The NF1 gene in tumor syndromes and melanoma

Area of Science:

• Oncology
• Genetics
• Dermatology

Background:

• The RAS/MAPK pathway is crucial in melanoma development.
• Melanoma is classified into four subtypes based on genetic drivers: BRAF, NRAS, NF1, and triple wild-type.
• Neurofibromin 1 (NF1) negatively regulates RAS proteins, and its germline mutations cause neurofibromatosis type I (a RASopathy).

Purpose of the Study:

• To review the current understanding of the NF1 gene and its protein product, neurofibromin 1.
• To discuss the role of NF1 in neurofibromatosis type I and melanoma.
• To highlight NF1-mutant melanoma characteristics and associations.

Main Methods:

• Literature review of scientific articles and clinical studies.
• Analysis of genetic drivers and molecular subtypes of melanoma.
• Examination of clinicopathologic features associated with NF1 mutations.

Main Results:

• NF1 mutations define a distinct melanoma subtype, often found in older individuals on sun-exposed skin.
• NF1-mutant melanomas typically exhibit a high mutation burden and are wild-type for BRAF and NRAS.
• NF1 mutations are particularly associated with desmoplastic melanoma.

Conclusions:

• NF1 plays a significant role in specific melanoma subtypes, distinct from BRAF and NRAS-driven tumors.
• Understanding NF1's function is critical for classifying and potentially treating certain melanomas.
• NF1 mutations are important biomarkers for specific melanoma clinicopathologic features.